Dechra Pharmaceuticals PLC

DCHPF · OTC
Analyze with AI
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating Activities
Net Income$6$96$77$52
Dep. & Amort.$90$89-$125$14
Deferred Tax$11-$40$0-$28
Stock-Based Comp.-$1$3$0$2
Change in WC-$60-$28-$50-$9
Other Non-Cash$18$2-$68$76
Operating Cash Flow$64$123$123$106
Investing Activities
PP&E Inv.-$30-$78-$186-$49
Net Acquisitions-$397-$1-$1-$33
Inv. Purchases$0$0-$1$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$1$0$0$1
Investing Cash Flow-$426-$78-$188-$82
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$182$2$3$132
Stock Repurch.-$15$4$0$140
Dividends Paid-$52-$45-$52-$33
Other Fin. Act.$368-$1$0$152
Financing Cash Flow$317-$46-$76$119
Forex Effect-$0$4$0$3
Net Chg. in Cash-$47$3$0$147
Supplemental Information
Beg. Cash$121$118$0$80
End Cash$74$121$0$227
Free Cash Flow$33$45$97$57